menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

MCED & PATHFINDER: Challenging the Status Quo in Cancer Screening

Details
Recommended

Overview

ReachMD Healthcare Image
RestartResume

Learn more about the current gaps in cancer screening, and how the results of the PATHFINDER study may help us close these gaps.

  • Sponsored by

  • Overview

    While the state of cancer screening hasn’t seen too many changes over the years, the results from the PATHFINDER study may offer clinicians a new screening tool. Dr. Eric Klein from the Glickman Urological and Kidney Institute dives into this clinical data and how it might impact cancer screening protocols.

Schedule21 Sep 2023